01—Abstract
Summary
Summary of the 8-K filed October 22, 2026. Cited figures are marked; the original filing is the authoritative source.
Quest Diagnostics Incorporated (DGX) reported on October 22, 2026, an Item 8.01 filing concerning a cybersecurity incident discovered on October 21, 2026.
The company identified unauthorized access to its Quanum LSM system, a platform used by clients for test ordering and results retrieval. Quest Diagnostics has initiated its cybersecurity response protocols, including notifying federal law enforcement and engaging external experts to investigate the nature and scope of the breach. While the full extent of the incident is still under investigation, the company currently believes that certain patient records may have been accessed.
Importantly, Quest Diagnostics stated that this incident has not materially disrupted its business operations or its ability to serve patients. Investors should note that forward-looking statements within this filing are subject to risks and uncertainties, including the potential impact of this incident and other factors outlined in the company's SEC filings.
02—Key points
Key Highlights
- Discovery of unauthorized access to Quanum LSM system on October 21, 2026.
- Incident response procedures have been initiated by Quest Diagnostics.
- Federal law enforcement has been notified.
- External cybersecurity experts have been engaged to assist in the investigation.
- Company believes certain patient records may have been accessed.
- Business operations and ability to serve patients have not been materially disrupted.
- Filing includes cautionary statements regarding forward-looking statements and associated risks.
03—Questions
Frequently Asked Questions
What is the Quanum LSM system mentioned in the filing?
The Quanum LSM system is a platform used by Quest Diagnostics' clients to place test orders and to receive and look up test results.
What is the immediate impact of this cybersecurity incident on Quest Diagnostics' business?
According to the filing, the incident has not materially disrupted Quest Diagnostics' business operations or its ability to serve patients.
What steps is Quest Diagnostics taking to address the incident?
Quest Diagnostics has initiated its cybersecurity incident response procedures, is investigating the nature and scope of the access, is implementing remedial measures, has notified federal law enforcement, and has engaged external cybersecurity experts.
Could this incident lead to financial penalties or significant costs for Quest Diagnostics?
The filing does not provide specific details on potential financial impacts. However, it does mention that the full scope is under investigation and refers to other risks and uncertainties in its SEC filings, which could include costs associated with investigations, remediation, and potential legal actions.
04—Continue